De-escalating cancer treatments during COVID 19 pandemic: Is metronomic chemotherapy a reasonable option?

por Fedele, Palma, Sanna, Valeria, Fancellu, Alessandro, Marino, Antonella, Calvani, Nicola, Cinieri, Saverio
Publicado 2021

Edmonton Symptom Assessment Scale may reduce medical visits in patients undergoing chemotherapy for breast cancer

por Sanna, Valeria, Fedele, Palma, Deiana, Giulia, Alicicco, Maria G, Ninniri, Chiara, Santoro, Anna N, Pazzola, Antonio, Fancellu, Alessandro
Publicado 2022

Targeted Therapy for Hepatocellular Carcinoma: Old and New Opportunities

por Laface, Carmelo, Fedele, Palma, Maselli, Felicia Maria, Ambrogio, Francesca, Foti, Caterina, Molinari, Pasquale, Ammendola, Michele, Lioce, Marco, Ranieri, Girolamo
Publicado 2022

The Treatment Landscape of Elderly Patients with Hormone Receptor-Positive Her2 Negative Advanced Breast Cancer: Current Perspectives and Future Directions

por Laface, Carmelo, Giuliani, Francesco, Melaccio, Assunta, Pappagallo, Maria Nicla, Santoro, Anna Natalizia, Perrone, Martina, De Santis, Pierluigi, Guarini, Chiara, Carrozzo, Daniela, Fedele, Palma
Publicado 2023

Immunotherapy in Prostate Cancer: State of Art and New Therapeutic Perspectives

por Maselli, Felicia Maria, Giuliani, Francesco, Laface, Carmelo, Perrone, Martina, Melaccio, Assunta, De Santis, Pierluigi, Santoro, Anna Natalizia, Guarini, Chiara, Iaia, Maria Laura, Fedele, Palma
Publicado 2023

The Resistance to EGFR-TKIs in Non-Small Cell Lung Cancer: From Molecular Mechanisms to Clinical Application of New Therapeutic Strategies

por Laface, Carmelo, Maselli, Felicia Maria, Santoro, Anna Natalizia, Iaia, Maria Laura, Ambrogio, Francesca, Laterza, Marigia, Guarini, Chiara, De Santis, Pierluigi, Perrone, Martina, Fedele, Palma
Publicado 2023

Immunotherapy and the Combination with Targeted Therapies for Advanced Hepatocellular Carcinoma

por Laface, Carmelo, Ranieri, Girolamo, Maselli, Felicia Maria, Ambrogio, Francesca, Foti, Caterina, Ammendola, Michele, Laterza, Marigia, Cazzato, Gerardo, Memeo, Riccardo, Mastrandrea, Giovanni, Lioce, Marco, Fedele, Palma
Publicado 2023

Immunotherapy and Pancreatic Cancer: A Lost Challenge?

por Laface, Carmelo, Memeo, Riccardo, Maselli, Felicia Maria, Santoro, Anna Natalizia, Iaia, Maria Laura, Ambrogio, Francesca, Laterza, Marigia, Cazzato, Gerardo, Guarini, Chiara, De Santis, Pierluigi, Perrone, Martina, Fedele, Palma
Publicado 2023

Metronomic oral chemotherapy with cyclophosphamide plus capecitabine combined with trastuzumab (HEX) as first line therapy of HER-2 positive advanced breast cancer: A phase II tria...

por Orlando, Laura, Lorusso, Vito, Giotta, Francesco, Di Maio, Massimo, Schiavone, Paola, Fedele, Palma, Quaranta, Annamaria, Caliolo, Chiara, Ciccarese, Mariangela, Cinefra, Margherita, Romito, Sante, Pisconti, Salvatore, Prete, Salvatore del, Aieta, Michele, Rizzi, Daniele, Maiello, Evaristo, Colucci, Giuseppe, Cinieri, Saverio
Publicado 2020

Eribulin plus trastuzumab in pretreated HER2-positive advanced breast cancer patients: safety and efficacy. An Italian experience

por Lutrino, Eufemia S., Orlando, Laura, Febbraro, Antonio, Giampaglia, Marianna, Zamagni, Claudio, Schiavone, Paola, Scavelli, Claudio, Dima, Gianluca, Fedele, Palma, Giordano, Guido, Bilancia, Domenico, Quaranta, Anna Maria, Rubino, Daniela, Filippelli, Gianfranco, Fontanella, Caterina, Caliolo, Chiara, Marino, Antonella, Calvani, Nicola, Ferrara, Pasqualinda, Cinieri, Saverio
Publicado 2019